The Unither Conference—Recent Advances in Nanomedical Structures and Devices
Bibliographic record
Abstract
New paradigms are shrinking our world and a classic technological revolution in medicine is unfolding. The agents of this revolution are microscopically small, products of a relatively nascent interdisciplinary field known as nanomedicine—the application of nanotechnology to healthcare. Nanomedicine, with all its excitement and expectation, is already influencing the pharmaceutical industry, especially in the design, formulation and delivery of therapeutics. Based on this broad theme, the 2nd Annual Unither Nanomedical and Telemedical Technology Conference was held in Orford, Quebec, Canada from February 24–27, 2009. United Therapeutics Corporation (www.unither.com/ UnitherHome.aspx), a biotechnology company headquartered in Silver Spring, Maryland, USA, sponsored this conference. The company focuses on the development and commercialization of unique products that address the unmet medical needs of patients with chronic and life-threatening cardiovascular disease, various infectious diseases and certain cancers. Martine Rothblatt, Ph.D., J.D. (Chairman and CEO of United Therapeutics Corporation) and Nobel Laureate Baruch S. Blumberg, M.D., Ph.D. (Distinguished Scientist at NASA Ames Research Center, California, US), chaired the conference. This year’s conference highlighted numerous cutting-edge presentations broken up into various sessions that focused on innovations in nanomedicine, telemedicine, and the applications of nanotechnology to the pharmaceutical, device and biotechnology industries. Approximately hundred researchers, engineers, physicians, ethicists, lawyers, business professionals, policy makers and venture capitalists were in attendance.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.004 | 0.003 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.002 | 0.002 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.004 | 0.004 |
| Open science | 0.002 | 0.002 |
| Research integrity | 0.004 | 0.006 |
| Insufficient payload (model declined to judge) | 0.018 | 0.010 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".